Abstract

Proprotein convertase subtilisin-kexin 9 (PCSK9) appears to be involved in multiple processes. A ProtoArray Human Protein Microarray was used to identify proteins interacting with biotinylated PCSK9. Fifteen novel proteins interacting with PCSK9 were identified using this technique. Only two of these proteins, sterol carrier protein 2 and hepatoma-derived growth factor, related protein 3, have known functions. The identification of proteins that could affect the expression/function of PCSK9 is of great interest due to potential implications in personalized medicine for hypercholesterolemic patients.

Highlights

  • Hypercholesterolemia, which is a major issue in the United States due to the number of patients that suffer this disease, is well-known to improve with diet, exercise, and in the majority of the case, with the use of anti-hypercholesterolemic treatments [1]

  • Centrifugation was performed at 1000 × g for 2 minutes, and the resulting flow-through that contained the rPCSK9 protein in PBS was used in the step

  • Human rPCSK9 was first biotinylated as indicated in Materials and Methods

Read more

Summary

Introduction

Hypercholesterolemia, which is a major issue in the United States due to the number of patients that suffer this disease, is well-known to improve with diet, exercise, and in the majority of the case, with the use of anti-hypercholesterolemic treatments [1]. A gene that has been identified as responsible for statin resistance is proprotein convertase subtilisin/kexin 9 (PCSK9) [4]. Another group of patients (10–25%) suffer from statin intolerance limiting the use of these drugs in these patients [2,3]. Serum levels of PCSK9 are associated positively with LDL levels in FH patients and appear to contribute to the phenotypic severity of the FH disorder [11,12] Both gain-of-function (GOF) and loss-of-function (LOF) mutations in the PCSK9 gene have been reported. The LOF mutations, on the other hand, result in hypocholesterolemia and protection against cardiovascular diseases [15,16]

Objectives
Methods
Results
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.